Psychopharmacology

, Volume 178, Issue 2–3, pp 286–295 | Cite as

Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder

  • Danielle C. Turner
  • Andrew D. Blackwell
  • Jonathan H. Dowson
  • Andrew McLean
  • Barbara J. Sahakian
Original Investigation

Abstract

Rationale

Features of childhood attention-deficit/hyperactivity disorder (ADHD) often persist into adulthood. It has been shown that adult ADHD is associated with various neurocognitive deficits, including impairments in spatial working memory (SWM) and attention. It is not known whether these deficits are ameliorated by methylphenidate in adult ADHD.

Objectives

The aim of this study was to evaluate the neurocognitive effects of a single dose of methylphenidate on SWM, visual memory, spatial span and sustained attention in adult ADHD.

Methods

Twenty-four adult patients, recruited from a specialised clinic for the assessment of adult ADHD, were entered into a double-blind, randomised, placebo-controlled crossover study using a single 30 mg dose of methylphenidate.

Results

Eighteen patients met DSM-IV criteria for adult ADHD. Methylphenidate resulted in an improvement in SWM performance and sustained attention, together with a speeding in response time, in these patients. Six patients with attentional difficulties, who did not meet a DSM-IV diagnosis of ADHD, showed a different pattern of response to methylphenidate compared to the ADHD group. For the combined group, moderate correlations were shown between childhood ratings of ADHD (both self-reported and informant ratings) and response to methylphenidate on the SWM task.

Conclusions

Adults with ADHD had a similar neurocognitive response to methylphenidate to that previously reported for childhood ADHD. Our results provide further support for the validity of the ADHD syndrome as defined by DSM-IV and indicate possible neurocognitive substrates for clinical improvement with chronic methylphenidate.

Keywords

Norepinephrine Dopamine Working memory Attention Impulsivity Human Attention-deficit/hyperactivity disorder Cognitive enhancement Spatial working memory 

Notes

Acknowledgements

We thank the patients for participating in this study, which was funded by a Wellcome Trust Programme grant awarded to Professors T.W. Robbins, B.J. Everitt, B.J. Sahakian and Dr. A.C. Roberts and completed within the MRC (UK) Centre for Behavioural and Clinical Neuroscience. D.C.T. and A.M. were funded by Research Studentships from the Medical Research Council of the UK. The experiments comply with the current laws of the United Kingdom.

References

  1. Adler LA, Chua HC (2002) Management of ADHD in adults. J Clin Psychiatry 63(Suppl 12):29–35Google Scholar
  2. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington D.C.Google Scholar
  3. Aron AR, Dowson JH, Sahakian BJ, Robbins TW (2003) Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 54:1465–1468CrossRefPubMedGoogle Scholar
  4. Barkley RA (1998) Attention deficit hyperactivity disorder: a handbook for diagnosis and treatment, 2nd edn. Guilford, New YorkGoogle Scholar
  5. Barkley RA, Grodzinsky G, DuPaul GJ (1992) Frontal lobe functions in attention deficit disorder with and without hyperactivity: a review and research report. J Abnorm Child Psychol 20:163–188PubMedGoogle Scholar
  6. Barkley RA, Murphy KR, Bush T (2001) Time perception and reproduction in young adults with attention deficit hyperactivity disorder. Neuropsychology 15:351–360CrossRefPubMedGoogle Scholar
  7. Barnett R, Maruff P, Vance A, Luk ES, Costin J, Wood C, Pantelis C (2001) Abnormal executive function in attention deficit hyperactivity disorder: the effect of stimulant medication and age on spatial working memory. Psychol Med 31:1107–1115CrossRefPubMedGoogle Scholar
  8. Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211–218Google Scholar
  9. Bor D, Duncan J, Wiseman RJ, Owen AM (2003) Encoding strategies dissociate prefrontal activity from working memory demand. Neuron 37:361–367CrossRefPubMedGoogle Scholar
  10. Bush G, Frazier JA, Rauch SL, Seidman LJ, Whalen PJ, Jenike MA, Rosen BR, Biederman J (1999) Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the counting stroop. Biol Psychiatry 45:1542–1552CrossRefPubMedGoogle Scholar
  11. Castellanos FX, Tannock R (2002) Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 3:617–628PubMedGoogle Scholar
  12. Castellanos FX, Giedd JN, Eckburg P, Marsh WL, Vaituzis AC, Kaysen D, Hamburger SD, Rapoport JL (1994) Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder. Am J Psychiatry 151:1791–1796PubMedGoogle Scholar
  13. Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Vaituzis AC, Dickstein DP, Sarfatti SE, Vauss YC, Snell JW, Lange N, Kaysen D, Krain AL, Ritchie GF, Rajapakse JC, Rapoport JL (1996) Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry 53:607–616Google Scholar
  14. Challman TD, Lipsky JJ (2000) Methylphenidate: its pharmacology and uses. Mayo Clin Proc 75:711–721PubMedGoogle Scholar
  15. Coull JT, Sahakian BJ, Middleton HC, Young AH, Park SB, McShane RH, Cowen PJ, Robbins TW (1995) Differential effects of clonidine, haloperidol, diazepam and tryptophan depletion on focused attention and attentional search. Psychopharmacology 121:222–230PubMedGoogle Scholar
  16. Derogatis LR (1993) Brief Symptom Inventory (BSI): administrative, scoring and procedural manual, 3rd edn. National Computer Systems, MinneapolisGoogle Scholar
  17. Dinn WM, Robbins NC, Harris CL (2001) Adult attention-deficit/hyperactivity disorder: neuropsychological correlates and clinical presentation. Brain Cogn 46:114–121PubMedGoogle Scholar
  18. Downey KK, Stelson FW, Pomerleau OF, Giordani B (1997) Adult attention deficit hyperactivity disorder: psychological test profiles in a clinical population. J Nerv Ment Dis 185:32–38CrossRefPubMedGoogle Scholar
  19. Dowson J, McLean A, Bazanis E, Toone B, Young S, Robbins TW, Sahakian BJ (2004) Impaired spatial working memory in adults with attention-deficit/hyperactivity disorder: comparisons with performance in adults and borderline personality disorder and in control subjects. Scand Acta Psychiatr 110:45–54CrossRefGoogle Scholar
  20. Elliott R, Sahakian BJ, Matthews K, Bannerjea A, Rimmer J, Robbins TW (1997) Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology 131:196–206CrossRefPubMedGoogle Scholar
  21. Ernst M, Kimes AS, London ED, Matochik JA, Eldreth D, Tata S, Contoreggi C, Leff M, Bolla K (2003) Neural substrates of decision making in adults with attention deficit hyperactivity disorder. Am J Psychiatry 160:1061–1070CrossRefPubMedGoogle Scholar
  22. Faraone SV, Biederman J, Feighner JA, Monuteaux MC (2000a) Assessing symptoms of attention deficit hyperactivity disorder in children and adults: which is more valid? J Consult Clin Psychol 68:830–842CrossRefPubMedGoogle Scholar
  23. Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, Doyle AE (2000b) Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry 48:9–20CrossRefPubMedGoogle Scholar
  24. Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J (2004) Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 24:24–29PubMedGoogle Scholar
  25. Gallagher R, Blader J (2001) The diagnosis and neuropsychological assessment of adult attention deficit/hyperactivity disorder. Scientific study and practical guidelines. Ann N Y Acad Sci 931:148–171PubMedGoogle Scholar
  26. Hesslinger B, Tebartz van Elst L, Mochan F, Ebert D (2003) A psychopathological study into the relationship between attention deficit hyperactivity disorder in adult patients and recurrent brief depression. Acta Psychiatr Scand 107:385–389CrossRefPubMedGoogle Scholar
  27. Howell DC (1997) Statistical methods for psychology, 4th edn. Wadsworth, LondonGoogle Scholar
  28. Hynd GW, Semrud-Clikeman M, Lorys AR, Novey ES, Eliopulos D (1990) Brain morphology in developmental dyslexia and attention deficit disorder/hyperactivity. Arch Neurol 47:919–926PubMedGoogle Scholar
  29. Hynd GW, Semrud-Clikeman M, Lorys AR, Novey ES, Eliopulos D, Lyytinen H (1991) Corpus callosum morphology in attention deficit-hyperactivity disorder: morphometric analysis of MRI. J Learn Disabil 24:141–146PubMedGoogle Scholar
  30. Hynd GW, Hern KL, Novey ES, Eliopulos D, Marshall R, Gonzalez JJ, Voeller KK (1993) Attention deficit-hyperactivity disorder and asymmetry of the caudate nucleus. J Child Neurol 8:339–347PubMedGoogle Scholar
  31. Jenkins M, Cohen R, Malloy P, Salloway S, Gillard Johnson E, Penn J, Marcotte A (1998) Neuropsychological measures which discriminate among adults with residual symptoms of attention deficit disorder and other attentional complaints. Clin Neuropsychol 12:74–83CrossRefGoogle Scholar
  32. Kempton S, Vance A, Maruff P, Luk E, Costin J, Pantelis C (1999) Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children. Psychol Med 29:527–538CrossRefPubMedGoogle Scholar
  33. Kimberg DY, D’Esposito M, Farah MJ (1997) Effects of bromocriptine on human subjects depend on working memory capacity. Neuroreport 8:3581–3585PubMedGoogle Scholar
  34. Kinsbourne M, De Quiros GB, Tocci Rufo D (2001) Adult ADHD. Controlled medication assessment. Ann N Y Acad Sci 931:287–296PubMedGoogle Scholar
  35. Logan GD, Schachar RJ, Tannock R (2000) Executive control problems in childhood psychopathology: stop signal studies of attention deficit hyperactivity disorder. In: Monsell S, Driver J (eds) Control of cognitive processes: attention and performance XVIII. MIT, Cambridge, pp 653–677Google Scholar
  36. Lou HC, Henriksen L, Bruhn P (1984) Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder. Arch Neurol 41:825–829Google Scholar
  37. Lou HC, Henriksen L, Bruhn P, Borner H, Nielsen JB (1989) Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch Neurol 46:48–52Google Scholar
  38. Lovejoy DW, Ball JD, Keats M, Stutts ML, Spain EH, Janda L, Janusz J (1999) Neuropsychological performance of adults with attention deficit hyperactivity disorder (ADHD): diagnostic classification estimates for measures of frontal lobe/executive functioning. J Int Neuropsychol Soc 5:222–233CrossRefPubMedGoogle Scholar
  39. Maidment ID (2003) Efficacy of stimulants in adult ADHD. Ann Pharmacother 37:1884–1890CrossRefPubMedGoogle Scholar
  40. Mannuzza S, Klein RG, Klein DF, Bessler A, Shrout P (2002) Accuracy of adult recall of childhood attention deficit hyperactivity disorder. Am J Psychiatry 159:1882–1888CrossRefPubMedGoogle Scholar
  41. McLean A, Dowson J, Toone B, Young S, Bazanis E, Robbins TW, Sahakian BJ (2004) Characteristic cognitive profile associated with adult attention-deficit/hyperactivity disorder. Psychol Med 34:1–12CrossRefGoogle Scholar
  42. Mehta MA, Sahakian BJ, McKenna PJ, Robbins TW (1999a) Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson’s disease. Psychopharmacology 146:162–174CrossRefPubMedGoogle Scholar
  43. Mehta MA, Sahakian BJ, Robbins TW (1999b) Comparative psychopharmacology of methylphenidate and related drugs in human volunteers, patients with ADHD and experimental animals. In: Solanto MV, Arnsten AF, Castellanos FX (eds) Stimulant drugs and ADHD: basic and clinical neuroscience. Oxford University Press, New York, pp 303–331Google Scholar
  44. Mehta MA, Calloway P, Sahakian BJ (2000a) Amelioration of specific working memory deficits by methylphenidate in a case of adult attention deficit/hyperactivity disorder. J Psychopharmacol 14:299–302PubMedGoogle Scholar
  45. Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD, Robbins TW (2000b) Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci 20(RC65):1–6PubMedGoogle Scholar
  46. Mehta MA, Goodyer IM, Sahakian BJ (2004) Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity. J Child Psychol Psychiatry 45:293–305CrossRefPubMedGoogle Scholar
  47. Murphy P (2002a) Cognitive functioning in adults with attention-deficit/hyperactivity disorder. J Attention Disord 5:203–209Google Scholar
  48. Murphy P (2002b) Inhibitory control in adults with attention-deficit/hyperactivity disorder. J Attention Disord 6:1–4Google Scholar
  49. Nelson H (1982) National adult reading test manual. NFER-Nelson, WindsorGoogle Scholar
  50. Nigg JT, Butler KM, Huang-Pollock CL, Henderson JM (2002) Inhibitory processes in adults with persistent childhood onset ADHD. J Consult Clin Psychol 70:153–157CrossRefPubMedGoogle Scholar
  51. NIH (1998) Diagnosis and treatment of attention deficit hyperactivity disorder. National Institutes of Health Consensus Statement, Nov 16–18, pp 1–37Google Scholar
  52. Ossmann JM, Mulligan NW (2003) Inhibition and attention deficit hyperactivity disorder in adults. Am J Psychol 116:35–50PubMedGoogle Scholar
  53. Owen AM, Downes JJ, Sahakian BJ, Polkey CE, Robbins TW (1990) Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia 28:1021–1034CrossRefPubMedGoogle Scholar
  54. Owen AM, Evans AC, Petrides M (1996) Evidence for a two-stage model of spatial working memory processing within the lateral frontal cortex: a positron emission tomography study. Cereb Cortex 6:31–38PubMedGoogle Scholar
  55. Park SB, Coull JT, McShane RH, Young AH, Sahakian BJ, Robbins TW, Cowen PJ (1994) Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuropharmacology 33:575–588CrossRefPubMedGoogle Scholar
  56. Pary R, Lewis S, Matuschka PR, Rudzinskiy P, Safi M, Lippmann S (2002) Attention deficit disorder in adults. Ann Clin Psychiatry 14:105–111CrossRefPubMedGoogle Scholar
  57. Pennington BF, Ozonoff S (1996) Executive functions and developmental psychopathology. J Child Psychol Psychiatry 37:51–87PubMedGoogle Scholar
  58. Postle BR, Stern CE, Rosen BR, Corkin S (2000) An fMRI investigation of cortical contributions to spatial and nonspatial visual working memory. Neuroimage 11:409–423CrossRefPubMedGoogle Scholar
  59. Rapoport JL, Buchsbaum MS, Weingartner H, Zahn TP, Ludlow C, Mikkelsen EJ (1980) Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men. Arch Gen Psychiatry 37:933–943PubMedGoogle Scholar
  60. Riordan HJ, Flashman LA, Saykin AJ, Frutiger SA, Carroll KE, Huey L (1999) Neuropsychological correlates of methylphenidate treatment in adult ADHD with and without depression. Arch Clin Neuropsychol 14:217–233CrossRefPubMedGoogle Scholar
  61. Rogers RD, Blackshaw AJ, Middleton HC, Matthews K, Hawtin K, Crowley C, Hopwood A, Wallace C, Deakin JF, Sahakian BJ, Robbins TW (1999) Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour. Psychopharmacology 146:482–491PubMedGoogle Scholar
  62. Seidman LJ, Biederman J, Weber W, Hatch M, Faraone SV (1998) Neuropsychological function in adults with attention-deficit hyperactivity disorder. Biol Psychiatry 44:260–268CrossRefPubMedGoogle Scholar
  63. Shaffer D (1994) Attention deficit hyperactivity disorder in adults. Am J Psychiatry 151:633–638PubMedGoogle Scholar
  64. Solanto MV (1998) Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 94:127–152CrossRefPubMedGoogle Scholar
  65. Solanto MV (2002) Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behav Brain Res 130:65–71CrossRefPubMedGoogle Scholar
  66. Spencer T, Biederman J, Wilens T, Faraone SV (1994) Is attention-deficit hyperactivity disorder in adults a valid disorder? Harv Rev Psychiatry 1:326–335PubMedGoogle Scholar
  67. Spencer T, Wilens T, Biederman J, Faraone SV, Ablon JS, Lapey K (1995) A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry 52:434–443PubMedGoogle Scholar
  68. Spencer T, Biederman J, Wilens TE, Faraone SV (1998) Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis. J Clin Psychiatry 59(Suppl 7):59–68PubMedGoogle Scholar
  69. Swanson JM (2003) Role of executive function in ADHD. J Clin Psychiatry 64(Suppl 14):35–39Google Scholar
  70. Swanson J, Castellanos FX, Murias M, LaHoste G, Kennedy J (1998) Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder. Curr Opin Neurobiol 8:263–271CrossRefPubMedGoogle Scholar
  71. Tannock R (1998) Attention deficit hyperactivity disorder: advances in cognitive, neurobiological, and genetic research. J Child Psychol Psychiatry 39:65–99CrossRefPubMedGoogle Scholar
  72. Tannock R, Ickowicz A, Schachar R (1995) Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 34:886–896CrossRefPubMedGoogle Scholar
  73. Triolo SJ, Murphy KR (1996) Attention-deficit scales for adults (ADSA). Manual for scoring and interpretation. Brunner/Maze, New YorkGoogle Scholar
  74. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ (2003a) Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology 165:260–269PubMedGoogle Scholar
  75. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ (2003b) Relative lack of cognitive effects of methylphenidate in elderly male volunteers. Psychopharmacology 168:455–464CrossRefPubMedGoogle Scholar
  76. Turner DC, Clark L, Dowson J, Robbins TW, Sahakian BJ (2004a) Modafinil improves cognition and response inhibition in adult ADHD. Biol Psychiatry 55:1031–1040CrossRefPubMedGoogle Scholar
  77. Turner DC, Clark L, Pomarol-Clotet E, McKenna P, Robbins TW, Sahakian BJ (2004b) Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology 29:1363–1373CrossRefPubMedGoogle Scholar
  78. Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Desmond JE, Glover GH, Gabrieli JD (1998) Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc Natl Acad Sci USA 95:14494–14499Google Scholar
  79. Walker AJ, Shores EA, Trollor JN, Lee T, Sachdev PS (2000) Neuropsychological functioning of adults with attention deficit hyperactivity disorder. J Clin Exp Neuropsychol 22:115–124CrossRefPubMedGoogle Scholar
  80. Wodushek TR, Neumann CS (2003) Inhibitory capacity in adults with symptoms of attention deficit/hyperactivity disorder (ADHD). Arch Clin Neuropsychol 18:317–330CrossRefPubMedGoogle Scholar
  81. Zametkin AJ, Liotta W (1998) The neurobiology of attention-deficit/hyperactivity disorder. J Clin Psychiatry 59(Suppl 7):17–23Google Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Danielle C. Turner
    • 1
  • Andrew D. Blackwell
    • 1
  • Jonathan H. Dowson
    • 1
  • Andrew McLean
    • 2
  • Barbara J. Sahakian
    • 1
  1. 1.Department of Psychiatry, School of Clinical Medicine, Addenbrooke’s HospitalUniversity of CambridgeCambridgeUK
  2. 2.Department of Psychological Medicine, University of GlasgowGartnavel Royal HospitalGlasgowUK

Personalised recommendations